NAUTILUS BIOTECHNOLOGY INC. - COMMON STOCK

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

18 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

31 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

30 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

29 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

08 أكتوبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

17 سبتمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

14 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

30 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

09 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

23 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

30 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

11 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28 فبراير 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

22 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

07 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

30 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

01 نوفمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

31 أكتوبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

11 أكتوبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire